Momotaro-Gene Inc. is the company whose main technology is REIC/Dkk-3 gene therapy. We are currently conducting two Phase IIa trial in the US. One is the monotherapy for localized prostate cancer and the other is combination therapy with Pd-1 inhibitor for malignant mesothelioma. We have a Japanese partner and Chinese partner. We are currently seeking US/EU partner for our technology.
Focus Areas
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
